Time-tested injectable drug with a patented technology of production of tylosin as a base specifically for the therapy of cats and dogs
|
Gram-positive |
Gram-negative |
Mycoplasma |
|
Corynebacterium spp. Streptococcus spp. Erysipelothrix spp. Bacillus anthracis Staphylococcus spp.
|
Escherichia coli Corynebacterium spp. Haemophilus spp. Pasteurella spp. Leptospira spp. |
Mycoplasma spp. |
|
Chlamydia |
||
|
Chlamydia spp. |
||
|
Spirochetes |
||
|
Brachispira spp. |
Tylosin 50 is used to treat:
|
Indicators |
Cats and dogs |
|
|
Dosage |
0.1-0.2 ml per 1 kg of animal body weight |
|
|
Method and frequency of administration |
Intramuscularly, once every 24 hours |
|
|
Treatment period |
5-7 days |
|
Contraindications and special instructions:
Simultaneous use of Tylosin 50 with thiamulin, clindamycin, levomycetin, penicillins (especially ampicillin and oxacillin), cephalosporins, lincomycin is not recommended due to a pronounced decrease in the antibacterial effect of tylosin.
